Trials / Completed
CompletedNCT01062074
GARDASIL Reexamination Study (V501-059)
Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,605 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 9 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of Gardasil through collecting the safety information according to the Re-examination Regulation for New Drugs.
Conditions
Timeline
- Start date
- 2007-09-28
- Primary completion
- 2013-05-07
- Completion
- 2013-05-07
- First posted
- 2010-02-04
- Last updated
- 2017-04-17
- Results posted
- 2014-03-27
Source: ClinicalTrials.gov record NCT01062074. Inclusion in this directory is not an endorsement.